Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative

Nicole M. Poole; Brian R. Lee; Matthew P. Kronman; Michael J. Smith; Sameer J. Patel; Rosemary Olivero; Bethany A. Wattles; Joshua Herigon; Ann Wirtz; Rana E. El Feghaly

doi:10.1016/j.ajic.2023.12.014

Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative

Nicole M. Poole, Brian R. Lee, Matthew P. Kronman, Michael J. Smith, Sameer J. Patel, Rosemary Olivero, Bethany A. Wattles, Joshua Herigon, Ann Wirtz, Rana E. El Feghaly^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in “pre-shortage” (Jan 2019-Sep 2022) and “shortage” (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing increased across settings, the proportion of amoxicillin prescriptions decreased. Variation was seen within and between institutions.

Original language	English (US)
Pages (from-to)	614-617
Number of pages	4
Journal	American Journal of Infection Control
Volume	52
Issue number	5
DOIs	https://doi.org/10.1016/j.ajic.2023.12.014
State	Published - May 2024

Funding

Funding/support: This study was supported by internal departmental funding from the Children’s Mercy Kansas City Pediatrics Department. Conflicts of interest: REE and BAW have grant funding from Merck for antimicrobial stewardship projects, none of which are related to the current study. None of the other authors have any conflicts of interest to disclose. All authors have submitted conflict of interest forms. Sharing Antimicrobial Reports for Pediatric Stewardship Outpatient (SHARPS-OP) Collaborative Authors: Holly Maples PharmD; Lauren Kushner MD; Hayden Schwenk MD; Meghan Birkholz MSPH; Saleh Ezzeldin MD, Michael Buhnerkempe PhD; Ana Vaughan MD, MPH; Mari Nakamura MD, MPH; Elizabeth Lloyd MD; Nicholas Dillman PharmD; Nipunie Rajapakse MD, MPH; Laura Dinnes PharmD; Anthony Diez; Kelly Flett MD, MMSc; Christine Tricarico, PharmD, MBA; Shankar Upadhyayula MD; David Haslam MD; Josh Courter PharmD; Diana Yu PharmD; Sophie Katz MD, MPH; Diana Nguyen DO; Jordan Burdine PharmD, MBA; Brendan Bettinger, PhD; Katie Ray PharmD; Michelle Mitchell MD; Louis Vernacchio MD, MSc; Jonathan Hatoun MD, MPH, MS; Jason Newland MD, MEd. These data and findings were presented as a poster at the annual International Pediatric Antimicrobial Stewardship Conference in St Louis, MO and a poster at IDWeek 2023 in Boston, MA. Conflicts of interest: REE and BAW have grant funding from Merck for antimicrobial stewardship projects, none of which are related to the current study. None of the other authors have any conflicts of interest to disclose. All authors have submitted conflict of interest forms. Funding/support: This study was supported by internal departmental funding from the Children's Mercy Kansas City Pediatrics Department.

Keywords

Amoxicillin shortage
Antimicrobial stewardship
Emergency department
Outpatient
Primary care clinic
Urgent care clinic

ASJC Scopus subject areas

Epidemiology
Health Policy
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ajic.2023.12.014

Cite this

Poole, N. M., Lee, B. R., Kronman, M. P., Smith, M. J., Patel, S. J., Olivero, R., Wattles, B. A., Herigon, J., Wirtz, A., & El Feghaly, R. E. (2024). Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative. American Journal of Infection Control, 52(5), 614-617. https://doi.org/10.1016/j.ajic.2023.12.014

@article{ab578611dbad402aa4ea21ce488a82ad,

title = "Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative",

abstract = "We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in “pre-shortage” (Jan 2019-Sep 2022) and “shortage” (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing increased across settings, the proportion of amoxicillin prescriptions decreased. Variation was seen within and between institutions.",

keywords = "Amoxicillin shortage, Antimicrobial stewardship, Emergency department, Outpatient, Primary care clinic, Urgent care clinic",

author = "Poole, {Nicole M.} and Lee, {Brian R.} and Kronman, {Matthew P.} and Smith, {Michael J.} and Patel, {Sameer J.} and Rosemary Olivero and Wattles, {Bethany A.} and Joshua Herigon and Ann Wirtz and {El Feghaly}, {Rana E.}",

note = "Publisher Copyright: {\textcopyright} 2024 Association for Professionals in Infection Control and Epidemiology, Inc.",

year = "2024",

month = may,

doi = "10.1016/j.ajic.2023.12.014",

language = "English (US)",

volume = "52",

pages = "614--617",

journal = "American Journal of Infection Control",

issn = "0196-6553",

publisher = "Mosby Inc.",

number = "5",

}

Poole, NM, Lee, BR, Kronman, MP, Smith, MJ, Patel, SJ, Olivero, R, Wattles, BA, Herigon, J, Wirtz, A & El Feghaly, RE 2024, 'Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative', American Journal of Infection Control, vol. 52, no. 5, pp. 614-617. https://doi.org/10.1016/j.ajic.2023.12.014

TY - JOUR

T1 - Ambulatory amoxicillin use for common acute respiratory infections during a national shortage

T2 - Results from the SHARPS-OP benchmarking collaborative

AU - Poole, Nicole M.

AU - Lee, Brian R.

AU - Kronman, Matthew P.

AU - Smith, Michael J.

AU - Patel, Sameer J.

AU - Olivero, Rosemary

AU - Wattles, Bethany A.

AU - Herigon, Joshua

AU - Wirtz, Ann

AU - El Feghaly, Rana E.

PY - 2024/5

Y1 - 2024/5

N2 - We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in “pre-shortage” (Jan 2019-Sep 2022) and “shortage” (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing increased across settings, the proportion of amoxicillin prescriptions decreased. Variation was seen within and between institutions.

AB - We quantified antibiotic prescribing for ambulatory pediatric acute respiratory illness at 22 institutions in “pre-shortage” (Jan 2019-Sep 2022) and “shortage” (Oct 2022-Mar 2023) periods for amoxicillin. While acute respiratory illness prescribing increased across settings, the proportion of amoxicillin prescriptions decreased. Variation was seen within and between institutions.

KW - Amoxicillin shortage

KW - Antimicrobial stewardship

KW - Emergency department

KW - Outpatient

KW - Primary care clinic

KW - Urgent care clinic

UR - http://www.scopus.com/inward/record.url?scp=85182363095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182363095&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2023.12.014

DO - 10.1016/j.ajic.2023.12.014

M3 - Article

C2 - 38158158

AN - SCOPUS:85182363095

SN - 0196-6553

VL - 52

SP - 614

EP - 617

JO - American Journal of Infection Control

JF - American Journal of Infection Control

IS - 5

ER -

Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this